Senti Bio (SNTI)sciences announced the appointment of James B. Trager, Ph.D. to its Scientific Advisory Board. Trager formerly served as the ...

This would require greater innovation, incentives for scaling-up of bio-based solutions, and the removal of policy and infrastructure bottlenecks. Addressing the regional imbalance would also be ...

MLB Opening Day 2025 is finally upon us and all eyes will be on the Los Angeles Dodgers after their World Series win in 2024. The Dodgers technically already opened their season with a sweep of ...

President Trump has announced that the US will impose tariffs on all cars and trucks imported into the country. Here’s where all EVs available in the US are assembled. Shortly after taking ...

On one hand, this rumor makes a fair amount of sense given that Metroid Prime 4 has only been announced to come to the original Nintendo Switch. While past rumors have suggested that the game ...

Boston-based Hill­star Bio on Tues­day be­came the lat­est im­munol­o­gy start­up launch, un­veil­ing a $67 mil­lion Se­ries A round ...

Hillstar Bio is revolutionizing autoimmune disease treatment through a precision-driven approach that selectively depletes pathogenic cells while preserving healthy ones. This method holds the ...

Hillstar Bio is revolutionizing autoimmune disease treatment through a precision-driven approach that selectively depletes pathogenic cells while preserving healthy ones. This method holds the promise ...

Chicago, Ill., March 24, 2025 (GLOBE NEWSWIRE) -- Transpire Technologies today announced the general availability of version 4 of its online litigation support platform and the introduction of the ...

Funding will support two Phase 2 clinical trials in alcohol and cocaine use disorders Company has initiated Phase 2 study in alcohol use disorder and plans to initiate cocaine studies over the ...

In the latest move to cement its “immunology powerhouse” status, Sanofi is handing over $600 million upfront for Dren Bio’s clinical-stage bispecific antibody, with more than $1 billion in ...

March 20 (Reuters) - Sanofi (SASY.PA), opens new tab on Thursday announced an agreement with biopharmaceutical company Dren Bio for the acquisition of its autoimmune disease treatment DR-0201.